A product containing 1.8 mg codeine per 100 mL, or 90 mg per dosage unit, with isoquinoline alkaloid opium or non-narcotic ingredients, is scheduled as:

A product containing 1.8 mg codeine per 100 mL, or 90 mg per dosage unit, with isoquinoline alkaloid opium or non-narcotic ingredients, is scheduled as:

• A. Schedule III
• B. Schedule II
• C. Schedule IV
• D. Not scheduled

Answer: (A)

The key idea is how codeine-containing products are scheduled based on how much codeine is in each dosage form and whether non-narcotic ingredients are present. When codeine is combined with non-narcotic ingredients, the preparation is placed in Schedule III as long as the codeine content does not exceed 90 mg per dosage unit (and related per-dose thresholds, like very low per-volume amounts, are not exceeded). Here, the product has 90 mg of codeine per dosage unit, and it includes non-narcotic ingredients (or opium-derived isoquinoline alkaloids) as part of the formulation. That combination plus the 90 mg per dosage unit limit fits Schedule III, which is less tightly regulated than Schedule II but more controlled than Schedule IV or unregulated products. If the codeine per dosage unit were higher than 90 mg, it would move to Schedule II.

The key idea is how codeine-containing products are scheduled based on how much codeine is in each dosage form and whether non-narcotic ingredients are present. When codeine is combined with non-narcotic ingredients, the preparation is placed in Schedule III as long as the codeine content does not exceed 90 mg per dosage unit (and related per-dose thresholds, like very low per-volume amounts, are not exceeded). Here, the product has 90 mg of codeine per dosage unit, and it includes non-narcotic ingredients (or opium-derived isoquinoline alkaloids) as part of the formulation. That combination plus the 90 mg per dosage unit limit fits Schedule III, which is less tightly regulated than Schedule II but more controlled than Schedule IV or unregulated products. If the codeine per dosage unit were higher than 90 mg, it would move to Schedule II.